# FDA Approves Saluda Medical's CAP24 Paddle Lead for Spinal Cord Stimulation

> fda · REPORTED · 2026-07-01

Saluda Medical announced FDA approval of its CAP24 paddle lead, allowing it to be marketed and sold in the United States. The approval expands the company's closed-loop spinal cord stimulation platform into the paddle lead segment of the implantable pain management device market.

About Saluda Medical: Saluda Medical develops closed-loop spinal cord stimulation systems for chronic pain management, using real-time sensing of the spinal cord's evoked compound action potentials to automatically adjust therapy.

- Company: Saluda Medical
- Sector: medical devices
- Primary source: https://www.todaysmedicaldevelopments.com/news/regulatory-roundup-july-2026/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.